Daniel Marcellino - Publications

Affiliations: 
Department of Neuroscience,Karolinska Institute,stockholm, sweden, Solna, Stockholms län, Sweden 

50 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Mediavilla T, Özalay Ö, Estévez-Silva HM, Frias B, Orädd G, Sultan FR, Brozzoli C, Garzón B, Lövdén M, Marcellino DJ. Learning-related contraction of gray matter in rodent sensorimotor cortex is associated with adaptive myelination. Elife. 11. PMID 36350292 DOI: 10.7554/eLife.77432  0.698
2022 Mao H, Mediavilla T, Estévez-Silva H, Marcellino D, Sultan F. Increase of vesicular glutamate transporter 2 co-expression in the deep cerebellar nuclei related to skilled reach learning. Brain Research. 1782: 147842. PMID 35192848 DOI: 10.1016/j.brainres.2022.147842  0.692
2022 Giacobbo BL, Özalay Ö, Mediavilla T, Ericsson M, Axelsson J, Rieckmann A, Sultan F, Marcellino D. The Aged Striatum: Evidence of Molecular and Structural Changes Using a Longitudinal Multimodal Approach in Mice. Frontiers in Aging Neuroscience. 14: 795132. PMID 35140600 DOI: 10.3389/fnagi.2022.795132  0.722
2022 Estévez-Silva HM, Mediavilla T, Giacobbo BL, Liu X, Sultan FR, Marcellino DJ. Pridopidine modifies disease phenotype in a SOD1 mouse model of amyotrophic lateral sclerosis. The European Journal of Neuroscience. PMID 35080077 DOI: 10.1111/ejn.15608  0.702
2021 Giacobbo BL, Mediavilla T, Marcellino DJ, Sultan F. Metabolic changes in an animal model of amyotrophic lateral sclerosis evaluated by [F]-FDG positron emission tomography. Translational Neurodegeneration. 10: 21. PMID 34162436 DOI: 10.1186/s40035-021-00246-1  0.686
2019 Kolan SS, Lidström T, Mediavilla T, Dernstedt A, Degerman S, Hultdin M, Björk K, Marcellino D, Forsell MNE. Growth-inhibition of cell lines derived from B cell lymphomas through antagonism of serotonin receptor signaling. Scientific Reports. 9: 4276. PMID 30862884 DOI: 10.1038/s41598-019-40825-x  0.709
2014 Sahlholm K, Marcellino D, Nilsson J, Ögren SO, Fuxe K, Ã…rhem P. Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D2 receptor. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 149-55. PMID 24074141 DOI: 10.1017/S1461145713000801  0.378
2013 Frankowska M, Marcellino D, Adamczyk P, Filip M, Fuxe K. Effects of cocaine self-administration and extinction on D2 -like and A2A receptor recognition and D2 -like/Gi protein coupling in rat striatum. Addiction Biology. 18: 455-66. PMID 22500978 DOI: 10.1111/j.1369-1600.2012.00452.x  0.339
2012 Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P. Voltage sensitivities and deactivation kinetics of histamine H₃ and Hâ‚„ receptors. Biochimica Et Biophysica Acta. 1818: 3081-9. PMID 22885137 DOI: 10.1016/J.Bbamem.2012.07.027  0.406
2012 Ferraro L, Frankowska M, Marcellino D, Zaniewska M, Beggiato S, Filip M, Tomasini MC, Antonelli T, Tanganelli S, Fuxe K. A novel mechanism of cocaine to enhance dopamine d2-like receptor mediated neurochemical and behavioral effects. An in vivo and in vitro study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1856-66. PMID 22453136 DOI: 10.1038/npp.2012.33  0.344
2012 Marcellino D, Kehr J, Agnati LF, Fuxe K. Increased affinity of dopamine for D(2) -like versus D(1) -like receptors. Relevance for volume transmission in interpreting PET findings. Synapse (New York, N.Y.). 66: 196-203. PMID 22034017 DOI: 10.1002/syn.21501  0.437
2011 Sahlholm K, Barchad-Avitzur O, Marcellino D, Gómez-Soler M, Fuxe K, Ciruela F, Arhem P. Agonist-specific voltage sensitivity at the dopamine D2S receptor--molecular determinants and relevance to therapeutic ligands. Neuropharmacology. 61: 937-49. PMID 21752340 DOI: 10.1016/J.Neuropharm.2011.06.022  0.424
2010 Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Gómez-Soler M, Corrales F, Marcellino D, Narvaez M, Frankowska M, Flajolet M, Heintz N, Agnati LF, Ciruela F, Fuxe K. Characterization of the A2AR-D2R interface: focus on the role of the C-terminal tail and the transmembrane helices. Biochemical and Biophysical Research Communications. 402: 801-7. PMID 21040702 DOI: 10.1016/J.Bbrc.2010.10.122  0.58
2010 Navarro G, Moreno E, Aymerich M, Marcellino D, McCormick PJ, Mallol J, Cortés A, Casadó V, Canela EI, Ortiz J, Fuxe K, Lluís C, Ferré S, Franco R. Direct involvement of sigma-1 receptors in the dopamine D1 receptor-mediated effects of cocaine. Proceedings of the National Academy of Sciences of the United States of America. 107: 18676-81. PMID 20956312 DOI: 10.1073/Pnas.1008911107  0.399
2010 Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Marcellino D, Ciruela F, Agnati LF, Fuxe K. Dopamine D2 and 5-hydroxytryptamine 5-HT(â‚‚A) receptors assemble into functionally interacting heteromers. Biochemical and Biophysical Research Communications. 401: 605-10. PMID 20888323 DOI: 10.1016/J.Bbrc.2010.09.110  0.585
2010 Fuxe K, Marcellino D, Borroto-Escuela DO, Frankowska M, Ferraro L, Guidolin D, Ciruela F, Agnati LF. The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor-receptor interactions. Journal of Receptor and Signal Transduction Research. 30: 272-83. PMID 20684666 DOI: 10.3109/10799893.2010.506191  0.605
2010 Marcellino D, Lindqvist E, Schneider M, Müller CE, Fuxe K, Olson L, Galter D. Chronic A2A antagonist treatment alleviates parkinsonian locomotor deficiency in MitoPark mice. Neurobiology of Disease. 40: 460-6. PMID 20656029 DOI: 10.1016/J.Nbd.2010.07.008  0.393
2010 Marcellino D, Suárez-Boomgaard D, Sánchez-Reina MD, Aguirre JA, Yoshitake T, Yoshitake S, Hagman B, Kehr J, Agnati LF, Fuxe K, Rivera A. On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 681-7. PMID 20387084 DOI: 10.1007/s00702-010-0400-0  0.407
2010 Ferraro L, Beggiato S, Marcellino D, Frankowska M, Filip M, Agnati LF, Antonelli T, Tomasini MC, Tanganelli S, Fuxe K. Nanomolar concentrations of cocaine enhance D2-like agonist-induced inhibition of the K+-evoked [3H]-dopamine efflux from rat striatal synaptosomes: a novel action of cocaine. Journal of Neural Transmission (Vienna, Austria : 1996). 117: 593-7. PMID 20354886 DOI: 10.1007/s00702-010-0389-4  0.319
2010 Marcellino D, Navarro G, Sahlholm K, Nilsson J, Agnati LF, Canela EI, Lluís C, Ã…rhem P, Franco R, Fuxe K. Cocaine produces D2R-mediated conformational changes in the adenosine A(2A)R-dopamine D2R heteromer. Biochemical and Biophysical Research Communications. 394: 988-92. PMID 20307491 DOI: 10.1016/J.Bbrc.2010.03.104  0.384
2010 Borroto-Escuela DO, Marcellino D, Narvaez M, Flajolet M, Heintz N, Agnati L, Ciruela F, Fuxe K. A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R. Biochemical and Biophysical Research Communications. 394: 222-7. PMID 20197060 DOI: 10.1016/J.Bbrc.2010.02.168  0.595
2010 Borroto-Escuela DO, Narvaez M, Marcellino D, Parrado C, Narvaez JA, Tarakanov AO, Agnati LF, Díaz-Cabiale Z, Fuxe K. Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochemical and Biophysical Research Communications. 393: 767-72. PMID 20171159 DOI: 10.1016/J.Bbrc.2010.02.078  0.618
2010 Genedani S, Carone C, Guidolin D, Filaferro M, Marcellino D, Fuxe K, Agnati LF. Differential sensitivity of A2A and especially D2 receptor trafficking to cocaine compared with lipid rafts in cotransfected CHO cell lines. Novel actions of cocaine independent of the DA transporter. Journal of Molecular Neuroscience : Mn. 41: 347-57. PMID 20143275 DOI: 10.1007/s12031-010-9328-y  0.371
2010 Fuxe K, Marcellino D, Leo G, Agnati LF. Molecular integration via allosteric interactions in receptor heteromers. A working hypothesis. Current Opinion in Pharmacology. 10: 14-22. PMID 19942481 DOI: 10.1016/j.coph.2009.10.010  0.436
2010 Fuxe K, Dahlström AB, Jonsson G, Marcellino D, Guescini M, Dam M, Manger P, Agnati L. The discovery of central monoamine neurons gave volume transmission to the wired brain. Progress in Neurobiology. 90: 82-100. PMID 19853007 DOI: 10.1016/j.pneurobio.2009.10.012  0.354
2010 de la Mora MP, Gallegos-Cari A, Arizmendi-García Y, Marcellino D, Fuxe K. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis. Progress in Neurobiology. 90: 198-216. PMID 19853006 DOI: 10.1016/j.pneurobio.2009.10.010  0.421
2009 Fuxe K, Marcellino D, Guidolin D, Woods AS, Agnati L. Brain receptor mosaics and their intramembrane receptor-receptor interactions: molecular integration in transmission and novel targets for drug development. Journal of Acupuncture and Meridian Studies. 2: 1-25. PMID 20633470 DOI: 10.1016/S2005-2901(09)60011-X  0.41
2009 Navarro G, Aymerich MS, Marcellino D, Cortés A, Casadó V, Mallol J, Canela EI, Agnati L, Woods AS, Fuxe K, Lluís C, Lanciego JL, Ferré S, Franco R. Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors. The Journal of Biological Chemistry. 284: 28058-68. PMID 19632986 DOI: 10.1074/Jbc.M109.034231  0.427
2009 Fuxe K, Marcellino D, Woods AS, Giuseppina L, Antonelli T, Ferraro L, Tanganelli S, Agnati LF. Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia. Journal of Neural Transmission (Vienna, Austria : 1996). 116: 923-39. PMID 19156349 DOI: 10.1007/S00702-008-0174-9  0.451
2008 Fuxe K, Marcellino D, Guidolin D, Woods AS, Agnati LF. Heterodimers and receptor mosaics of different types of G-protein-coupled receptors. Physiology (Bethesda, Md.). 23: 322-32. PMID 19074740 DOI: 10.1152/Physiol.00028.2008  0.397
2008 Sahlholm K, Marcellino D, Nilsson J, Fuxe K, Arhem P. Voltage-sensitivity at the human dopamine D2S receptor is agonist-specific. Biochemical and Biophysical Research Communications. 377: 1216-21. PMID 18983826 DOI: 10.1016/J.Bbrc.2008.10.117  0.387
2008 Sahlholm K, Marcellino D, Nilsson J, Fuxe K, Arhem P. Differential voltage-sensitivity of D2-like dopamine receptors. Biochemical and Biophysical Research Communications. 374: 496-501. PMID 18652803 DOI: 10.1016/J.Bbrc.2008.07.052  0.427
2008 Marcellino D, Ferré S, Casadó V, Cortés A, Le Foll B, Mazzola C, Drago F, Saur O, Stark H, Soriano A, Barnes C, Goldberg SR, Lluis C, Fuxe K, Franco R. Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. The Journal of Biological Chemistry. 283: 26016-25. PMID 18644790 DOI: 10.1074/jbc.M710349200  0.436
2008 Woods AS, Marcellino D, Jackson SN, Franco R, Ferré S, Agnati LF, Fuxe K. How calmodulin interacts with the adenosine A(2A) and the dopamine D(2) receptors. Journal of Proteome Research. 7: 3428-34. PMID 18590318 DOI: 10.1021/Pr8001782  0.437
2008 Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P. Electrophysiology-based analysis of human histamine H(4) receptor pharmacology using GIRK channel coupling in Xenopus oocytes. European Journal of Pharmacology. 591: 52-8. PMID 18582456 DOI: 10.1016/J.Ejphar.2008.06.029  0.389
2008 Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P. Voltage-dependence of the human dopamine D2 receptor. Synapse (New York, N.Y.). 62: 476-80. PMID 18361445 DOI: 10.1002/Syn.20509  0.443
2008 Marcellino D, Carriba P, Filip M, Borgkvist A, Frankowska M, Bellido I, Tanganelli S, Müller CE, Fisone G, Lluis C, Agnati LF, Franco R, Fuxe K. Antagonistic cannabinoid CB1/dopamine D2 receptor interactions in striatal CB1/D2 heteromers. A combined neurochemical and behavioral analysis. Neuropharmacology. 54: 815-23. PMID 18262573 DOI: 10.1016/J.Neuropharm.2007.12.011  0.451
2008 Borgkvist A, Marcellino D, Fuxe K, Greengard P, Fisone G. Regulation of DARPP-32 phosphorylation by Delta9-tetrahydrocannabinol. Neuropharmacology. 54: 31-5. PMID 17686497 DOI: 10.1016/J.Neuropharm.2007.06.025  0.402
2007 Fuxe K, Marcellino D, Genedani S, Agnati L. Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1990-2017. PMID 17618524 DOI: 10.1002/mds.21440  0.427
2007 Sahlholm K, Nilsson J, Marcellino D, Fuxe K, Arhem P. The human histamine H3 receptor couples to GIRK channels in Xenopus oocytes. European Journal of Pharmacology. 567: 206-10. PMID 17537431 DOI: 10.1016/J.Ejphar.2007.04.032  0.37
2007 Fuxe K, Dahlström A, Höistad M, Marcellino D, Jansson A, Rivera A, Diaz-Cabiale Z, Jacobsen K, Tinner-Staines B, Hagman B, Leo G, Staines W, Guidolin D, Kehr J, Genedani S, et al. From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission. Brain Research Reviews. 55: 17-54. PMID 17433836 DOI: 10.1016/J.Brainresrev.2007.02.009  0.382
2007 Marcellino D, Roberts DC, Navarro G, Filip M, Agnati L, Lluís C, Franco R, Fuxe K. Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal. Brain Research. 1143: 208-20. PMID 17320828 DOI: 10.1016/j.brainres.2007.01.079  0.379
2005 Fuxe K, Ferré S, Canals M, Torvinen M, Terasmaa A, Marcellino D, Goldberg SR, Staines W, Jacobsen KX, Lluis C, Woods AS, Agnati LF, Franco R. Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function. Journal of Molecular Neuroscience : Mn. 26: 209-20. PMID 16012194 DOI: 10.1385/Jmn:26:2-3:209  0.423
2005 Torvinen M, Torri C, Tombesi A, Marcellino D, Watson S, Lluis C, Franco R, Fuxe K, Agnati LF. Trafficking of adenosine A2A and dopamine D2 receptors. Journal of Molecular Neuroscience : Mn. 25: 191-200. PMID 15784967 DOI: 10.1385/JMN:25:2:191  0.433
2005 Torvinen M, Marcellino D, Canals M, Agnati LF, Lluis C, Franco R, Fuxe K. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes. Molecular Pharmacology. 67: 400-7. PMID 15539641 DOI: 10.1124/mol.104.003376  0.438
2004 Ciruela F, Burgueño J, Casadó V, Canals M, Marcellino D, Goldberg SR, Bader M, Fuxe K, Agnati LF, Lluis C, Franco R, Ferré S, Woods AS. Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Analytical Chemistry. 76: 5354-63. PMID 15362892 DOI: 10.1021/Ac049295F  0.405
2004 Ferré S, Ciruela F, Canals M, Marcellino D, Burgueno J, Casadó V, Hillion J, Torvinen M, Fanelli F, Benedetti Pd Pd, Goldberg SR, Bouvier M, Fuxe K, Agnati LF, Lluis C, et al. Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism & Related Disorders. 10: 265-71. PMID 15196504 DOI: 10.1016/J.Parkreldis.2004.02.014  0.45
2004 Canals M, Burgueño J, Marcellino D, Cabello N, Canela EI, Mallol J, Agnati L, Ferré S, Bouvier M, Fuxe K, Ciruela F, Lluis C, Franco R. Homodimerization of adenosine A2A receptors: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. Journal of Neurochemistry. 88: 726-34. PMID 14720222 DOI: 10.1046/J.1471-4159.2003.02200.X  0.429
2003 Canals M, Marcellino D, Fanelli F, Ciruela F, de Benedetti P, Goldberg SR, Neve K, Fuxe K, Agnati LF, Woods AS, Ferré S, Lluis C, Bouvier M, Franco R. Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. The Journal of Biological Chemistry. 278: 46741-9. PMID 12933819 DOI: 10.1074/Jbc.M306451200  0.43
2003 Franco R, Canals M, Marcellino D, Ferré S, Agnati L, Mallol J, Casadó V, Ciruela F, Fuxe K, Lluis C, Canela EI. Regulation of heptaspanning-membrane-receptor function by dimerization and clustering. Trends in Biochemical Sciences. 28: 238-43. PMID 12765835 DOI: 10.1016/S0968-0004(03)00065-3  0.401
Show low-probability matches.